Angiographic results of the cobalt chromium vision and mini-vision stents

Canadian Journal of Cardiology

Volumn 25, Issue 10, 2009, Pages 581-584

  Wöhrle, Jochen ^a   Nusser, Thorsten ^a   Hoffman, Stephanie ^a   Kochs, Matthias ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Cobalt chromium; Late loss; Restenosis; Stents

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CLOPIDOGREL; HEPARIN;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ANGIOPLASTY; AORTA BALLOON; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERTENSION; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS;

EID: 70350168783     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(09)70716-0     Document Type: Article

References (11)

1. Stone GW, Ellis SG, Cox DA, et al; TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31.
2. Moses JW, Leon MB, Popma JJ, et al; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23.
3. Fajadet J, Wijns W, Laarman GJ, et al. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: Clinical and angiographic results of the ENDEAVOR II trial. Circulation 2006;114:798-806.
4. Pinto DS, Stone GW, Ellis SG, et al. Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: Results from the TAXUS-IV trial. J Am Coll Cardiol 2006;48:32-6.
5. Hamm CW, Auch-Schwelk W, Bonzel T; for the DaVinci Registry participants. DaVinci Registry. EuroPCR 2005. (Version current at July 20, 2009).
6. Kaiser C, Brunner-La Rocca HP, et al. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: Randomised Basel Stent Kosten Effektivitats Trial (BASKET). Lancet 2005;366:921-9.
7. Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome. Circulation 1999;100:1872-8.
8. Kastrati A, Mehilli J, Dirschinger J, et al. Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation 2001;103:2816-21.
9. Pache J, Kastrati A, Mehilli J, et al. Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome (ISAR-STEREO) trial. J Am Coll Cardiol 2003;41:1283-8.
10. Stone GW, Ellis SG, Cannon L, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease. JAMA 2005;294:1215-23.
11. Mehilli J, Dibra A, Kastrati A, et al. Intracoronary drug-eluting stenting to abrogate restenosis in small arteries (ISAR-SMART 3) Study Investigators. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. Eur Heart J 2006;27:260-6.